Testimonials
Billionaires including Elon Musk and Michael Rubin of Fanatics have sung the praises of GLP-1 drugs including Wegovy and Ozempic for weight loss. Here are a few resources to understand the trends and what manage care pharmacists need to know.
It’s crucial that MCPs are armed with the tools they need to ensure patients get the medications they need at a cost they can afford—and that starts with you.
AMCP 2024 AAO Report
AMCP's feature annual report explores how professionals in managed care pharmacy work diligently to facilitate appropriate access to prescription treatments while remaining mindful of rising costs. It discusses key areas of focus such as pharmacy benefit design, formulary management, clinical programs, quality, safety and promoting affordability of medicines.
AMCP eModel is the ultimate tool for communication of health economic models and value evidence. Find out more about this tech partnership and this health economic modeling platform to support the exchange of clinical and economic information between manufacturers and payers.
AMCP partners with FormularyDecisions to enhance information sharing and formulary decision-making by creating a platform for current, credible, and compliant information exchange between life science companies and active, qualified healthcare decision-makers.
Meetings Proceedings & Findings
This glossary defines or describes terminology used in comparative clinical effectiveness research for managed care pharmacy professionals. For cost effectiveness terminology, please see other resources, such as Health Care Cost, Quality, and Outcomes: ISPOR Book of Terms. Lawrenceville, NJ: International Society for Pharmacoeconomics and Outcomes Research; 2003.
A project description, implementation overview, and lessons learned from the NOVA Southeastern University's AMCP Chapter Medication Therapy Management (MTM) Competition.
The purpose of this document is to help guide designers of MTM programs to identify the critical elements that support an effective, sound MTM program and allow these programs to be constructive in encouraging positive patient outcomes.
